PUBLISHER: The Business Research Company | PRODUCT CODE: 1942640
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942640
A cryostat is a medical equipment designed to maintain tissue sections at a constant low temperature and slice them into thin sections for microscopic examination, facilitating the diagnosis of various diseases and ailments. It is instrumental in preserving frozen tissue samples.
The major types of cryostats include closed-cycle cryostats, continuous-flow cryostats, bath cryostats, and multistage cryostats. Closed-cycle cryostats are helium-free systems that enable cooling down to liquid helium temperatures without the use of traditional cryogens. The components of the system include dewars, transfer tubes, gas flow pumps, temperature controllers, high vacuum pumps, and microtone blades, with various cryogens such as helium and nitrogen. Cryostats find applications in various industries, including healthcare, energy and power, aeronautics, metallurgy, biotechnology, forensic science, and marine biology.
Tariffs are impacting the cryostat market by increasing costs of imported vacuum components, precision motors, temperature controllers, sensors, and cryogenic materials used in closed-cycle and continuous-flow systems. Healthcare and research institutions in North America and Europe are most affected due to reliance on imported high-precision components, while Asia-Pacific faces cost pressure on equipment manufacturing. These tariffs are raising procurement costs and extending replacement cycles. However, they are also encouraging localized assembly, regional supplier development, and innovation in cost-optimized cryogenic equipment manufacturing.
The cryostat market research report is one of a series of new reports from The Business Research Company that provides cryostat market statistics, including cryostat industry global market size, regional shares, competitors with a cryostat market share, detailed cryostat market segments, market trends and opportunities, and any further data you may need to thrive in the cryostat industry. This cryostat market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cryostat market size has grown strongly in recent years. It will grow from $2.68 billion in 2025 to $2.89 billion in 2026 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to increasing use of frozen section diagnostics, expansion of pathology laboratories, rising demand for advanced histological analysis, growth in biomedical research activities, availability of liquid nitrogen infrastructure.
The cryostat market size is expected to see strong growth in the next few years. It will grow to $3.88 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to increasing demand for rapid intraoperative diagnostics, rising investments in advanced laboratory automation, growing focus on precision medicine research, expansion of biotechnology applications, technological improvements in cryogenic systems. Major trends in the forecast period include increasing adoption of high-precision cryosectioning systems, rising demand for automated temperature control mechanisms, growing integration of digital monitoring interfaces, expansion of multi-stage cryostat configurations, enhanced focus on sample preservation accuracy.
The increasing prevalence of infectious diseases is playing a significant role in driving the expansion of the cryostat market. Infectious diseases are widespread conditions caused by the transmission of pathogens such as viruses, bacteria, fungi, or parasites. The application of cryostats in the context of infectious disease management is particularly important due to the inherent risks involved in handling infectious agents. Tissue specimens can harbor pathogens, and samples collected from patients who are confirmed or suspected to be infected require stringent handling procedures. For example, in June 2024, data from the UK Health Security Agency, a United Kingdom-based government body, showed that between week 40 of 2022 and week 15 of 2023, 108 National Health Service trusts in England recorded 1,681 critical care admissions linked to confirmed influenza cases. By comparison, the prior season reported 182 admissions across 114 trusts, which increased to 316 by week 39 of 2022. As a result, the growing burden of infectious diseases is anticipated to support continued growth in the cryostat market.
Leading companies in the cryostat market are developing innovative products, such as helium recovery solutions, aimed at enhancing sustainability, lowering operational costs, and improving the efficiency of cryogenic systems. Helium recovery solutions are systems specifically designed to capture, recycle, and reuse helium, a precious and limited resource widely used in cryogenic applications like cryostats. For example, in April 2024, Bluefors, a UK-based manufacturer of cryogenic measurement systems, launched the Cryomech HeRL02-RM. This specialized helium recovery solution is intended for single Nuclear Magnetic Resonance (NMR) systems. The HeRL02-RM establishes a closed-loop system that captures boiled-off helium from NMR magnets, redirecting it through a vapor return line to a Pulse Tube Cryocooler-powered liquefier, where it is rapidly liquefied and returned to the magnet's helium bath.
In January 2025, Danaher Cryogenics Inc., a United States-based research technology company, completed the acquisition of the Adiabatic Demagnetization Refrigerator (ADR) cryostat product line from High Precision Devices Inc. for an undisclosed sum. Through this transaction, Danaher Cryogenics sought to enhance and broaden its sub-kelvin product offering by adding ADR cryostats capable of achieving ultra-low temperatures of approximately 30 to 100 millikelvin. This move addressed a technological gap between its existing sorption coolers and dilution refrigerators and reinforced its position in high-precision research fields, including quantum computing, astronomy, and condensed matter physics. High Precision Devices Inc. is a United States-based cryogenics company known for the design and manufacture of ADR cryostats and other high-precision cryogenic systems used by advanced research institutions.
Major companies operating in the cryostat market are Lake Shore Cryotronics Inc, Cryomech Inc, Epredia, Hacker Instruments & Industries Inc, Histo-Line Laboratories Srl, Jinhua YIDI Medical Appliance Co Ltd, SLEE Medical GmbH, Leica Biosystems, MEDITE Medical GmbH, Boeckeler Instruments Inc, Bright Instruments Ltd, Precision Cryogenics Systems Inc, Biobase Biodusty Co Ltd, Thermo Fisher Scientific Inc, Oxford Instruments, Quantum Design, ICE Oxford, Cryogenic Limited, Bluefors, Cryoquip, CryoMAgnetics, Vacree Technologies
North America was the largest region in the cryostat market in 2025. Asia-Pacific is expected to be the fastest-growing region in the cryostat market during the forecast period. The regions covered in the cryostat market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cryostat market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The cryostat market consists of sales of single compressor, double compressor, rotary cryostat, and motorized cryostat. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The cryostat market is segmented into single compressor, double compressor, rotary cryostat and other cryostats.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cryostat Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cryostat market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cryostat ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cryostat market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.